188 related articles for article (PubMed ID: 27236709)
1. Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis.
Campello E; Zanetto A; Spiezia L; Radu CM; Gavasso S; Ferrarese A; Farinati F; Senzolo M; Simioni P
Thromb Res; 2016 Jul; 143():118-21. PubMed ID: 27236709
[No Abstract] [Full Text] [Related]
2. [Comparison of pathological features between hepatocellular carcinoma with and without liver cirrhosis].
Lai RQ
Zhonghua Bing Li Xue Za Zhi; 1988 Dec; 17(4):289-91. PubMed ID: 2855473
[No Abstract] [Full Text] [Related]
3. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
[TBL] [Abstract][Full Text] [Related]
4. [Association of liver cirrhosis with amebic liver abscess and hepatoma].
Vargas de la Cruz J
Cir Cir; 1971 Jan; 39(1):749-60. PubMed ID: 4331341
[No Abstract] [Full Text] [Related]
5. [Clinicopathologic features of hepatocellular carcinoma: an analysis of 185 cases].
Wang YL; Du JL; Shi HY; Guo AT; Wei LX
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):609-13. PubMed ID: 21122415
[TBL] [Abstract][Full Text] [Related]
6. [Late presentation of Wilson's disease as cirrhosis complicating hepatocellular carcinoma].
Agret F; Vallet-Pichard A; Landau A; Carnot F; Pol S
Gastroenterol Clin Biol; 2003 Jan; 27(1):130-1. PubMed ID: 12594382
[No Abstract] [Full Text] [Related]
7. More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC.
Zanetto A; Campello E; Bulato C; Gavasso S; Saggiorato G; Shalaby S; Spiezia L; Cillo U; Farinati F; Russo FP; Burra P; Senzolo M; Simioni P
Hepatol Commun; 2021 Dec; 5(12):1987-2000. PubMed ID: 34558850
[TBL] [Abstract][Full Text] [Related]
8. Education and imaging. Hepatobiliary and pancreatic: hepatocellular carcinoma without cirrhosis.
Butte JM; Valbuena JR; Huete A; Martínez J
J Gastroenterol Hepatol; 2007 Dec; 22(12):2359. PubMed ID: 18031401
[No Abstract] [Full Text] [Related]
9. A Glycomics-Based Test Predicts the Development of Hepatocellular Carcinoma in Cirrhosis.
Verhelst X; Vanderschaeghe D; Castéra L; Raes T; Geerts A; Francoz C; Colman R; Durand F; Callewaert N; Van Vlierberghe H
Clin Cancer Res; 2017 Jun; 23(11):2750-2758. PubMed ID: 27986746
[No Abstract] [Full Text] [Related]
10. Cirrhosis and malignant hepatoma in alpha 1-antitrypsin deficiency.
Eriksson S; Hägerstrand I
Acta Med Scand; 1974 Jun; 195(6):451-8. PubMed ID: 4365922
[No Abstract] [Full Text] [Related]
11. Diagnostic value of serum copper, zinc and plasma fibrinogen in cirrhotic patients with and without hepatocellular carcinoma.
Doğan UB; Cindoruk M; Dumlu S; Unlü R; Unal S
Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):476-7. PubMed ID: 9494860
[No Abstract] [Full Text] [Related]
12. Early detection of hepatoma in cirrhosis by serial quantitation of alpha-1-foetoprotein in serum.
Niermeijer P; Gips CH; Marrink J; QUE GS
Neth J Med; 1976; 19(1):25-8. PubMed ID: 55985
[No Abstract] [Full Text] [Related]
13. Early detection of hepatoma in cirrhosis by serial quantitation of alpha-1-foetoprotein in serum.
Niermeijer P; Gips CH; Marrink J; Qué GS
Neth J Med; 1976; 19(1):15-8. PubMed ID: 55984
[No Abstract] [Full Text] [Related]
14. Diagnosis of hepatocellular carcinoma by fine needle biopsy of portal vein thrombosis.
de Sio I; Castellano L; Calandra M; Falzarano IR; Zeppa P
Ital J Gastroenterol; 1992 Feb; 24(2):75-6. PubMed ID: 1374276
[TBL] [Abstract][Full Text] [Related]
15. [Hepatocellular carcinoma in non-cirrhotic liver and ulcerative colitis: incidental or casual relationship?].
Ramia JM; Garrote D; Mansilla A; Villar J; Gómez R; Ferrón JA
Rev Esp Enferm Dig; 2004 Jun; 96(6):429-31. PubMed ID: 15230675
[No Abstract] [Full Text] [Related]
16. Primary liver cell carcinoma and post-necrotic cirrhosis associated with Australia antigen and alpha-feto protein. (A case report).
Malaviya AN; Nayak NC
J Assoc Physicians India; 1971 Oct; 19(10):697-700. PubMed ID: 4332064
[No Abstract] [Full Text] [Related]
17. [N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus].
Liu XE; Desmyter L; Gao CF; Laroy W; Dewaele S; Vanhooren V; Wang L; Zhuang H; Callewaert N; Libert C; Contreras R; Chen CY
Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):74-5. PubMed ID: 18226355
[No Abstract] [Full Text] [Related]
18. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
[TBL] [Abstract][Full Text] [Related]
19. Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis.
Henry L; Lavabre-Bertrand T; Vercambre L; Ramos J; Carillo S; Guiraud I; Pouderoux P; Bismuth M; Valats JC; Demattei C; Duny Y; Chaze I; Funakoshi N; Bureau JP; Daurès JP; Blanc P
Gut; 2009 Jun; 58(6):833-8. PubMed ID: 19201777
[TBL] [Abstract][Full Text] [Related]
20. Prospective validation of the Cancer of the Liver Italian Program (CLIP) score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma.
Llovet JM; Bruix J
Hepatology; 2000 Sep; 32(3):679-80. PubMed ID: 10991637
[No Abstract] [Full Text] [Related]
[Next] [New Search]
